AtriCure, Inc. (ATRC)
49.28
+0.30
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
49.27
-0.01
(-0.02%)
After-Hours: 20:00
AtriCure Shareholders Equity (Quarterly) : 516.43M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 516.43M |
| March 31, 2026 | 491.69M |
| December 31, 2025 | 491.94M |
| September 30, 2025 | 476.51M |
| June 30, 2025 | 464.49M |
| March 31, 2025 | 454.62M |
| December 31, 2024 | 460.97M |
| September 30, 2024 | 465.02M |
| June 30, 2024 | 462.08M |
| March 31, 2024 | 456.31M |
| December 31, 2023 | 466.17M |
| September 30, 2023 | 462.83M |
| June 30, 2023 | 462.42M |
| March 31, 2023 | 454.84M |
| December 31, 2022 | 456.75M |
| September 30, 2022 | 450.31M |
| June 30, 2022 | 456.71M |
| March 31, 2022 | 462.82M |
| December 31, 2021 | 483.76M |
| September 30, 2021 | 488.47M |
| June 30, 2021 | 385.08M |
| March 31, 2021 | 391.24M |
| December 31, 2020 | 412.39M |
| September 30, 2020 | 417.53M |
| June 30, 2020 | 416.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 227.37M |
| December 31, 2019 | 247.34M |
| September 30, 2019 | 258.22M |
| June 30, 2019 | 241.55M |
| March 31, 2019 | 239.29M |
| December 31, 2018 | 249.38M |
| September 30, 2018 | 163.77M |
| June 30, 2018 | 159.69M |
| March 31, 2018 | 153.12M |
| December 31, 2017 | 161.17M |
| September 30, 2017 | 158.92M |
| June 30, 2017 | 161.50M |
| March 31, 2017 | 160.86M |
| December 31, 2016 | 168.44M |
| September 30, 2016 | 173.43M |
| June 30, 2016 | 177.00M |
| March 31, 2016 | 181.03M |
| December 31, 2015 | 186.68M |
| September 30, 2015 | 125.48M |
| June 30, 2015 | 128.69M |
| March 31, 2015 | 128.56M |
| December 31, 2014 | 132.54M |
| September 30, 2014 | 135.04M |
| June 30, 2014 | 134.22M |
| March 31, 2014 | 134.26M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 24.93B |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 676.64M |
| Total Liabilities (Quarterly) | 160.21M |
| Debt to Equity Ratio | 0.1437 |
| Current Ratio | 4.218 |
| Net Debt Paydown Yield | 0.04% |